The Inflation Reduction Act was passed in 2021 to reduce the government deficit, incentivize domestic energy production, and ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Drug development has long been an issue for the ... hopes to involve five million adult volunteers. The future of R&D The Our Future Health project was funded from various bodies, but the pharma ...

Consider issues related to the lack of workforce diversity, lessons learned from related fields, and approaches for engaging and preparing a more diverse person-centered drug R&D workforce, ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...

Syneron has granted AstraZeneca access to its Synova™ platform, a high-throughput macrocyclic peptide drug R&D platform designed to advance research “exploring possible future treatments of ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

patients can wait more than ten years from initial drug discovery to its availability as a treatment. With autoimmune diseases and cancer rates increasing, the pharmaceutical industry’s R&D ...

Aiming to be a healthcare group with a global presence, Fosun Pharma, established in Shanghai in 1994, has built its core business around innovative drug R&D and manufacturing. Fosun Pharma’s ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen. After a year ...